Searched for
AUROBINDO PHARMA SUBSIDIARY
Aurobindo Pharma clears key US hurdle in Lannett acquisition, closing expected soonIndian drug giant Aurobindo Pharma is set for a major US expansion. The company has received crucial antitrust clearance from the US Federa...- Stocks in news: Rajesh Exports, Lenskart, Suzlon Energy, Aurobindo Pharma, Tata MotorsIndian markets saw volatility and closed lower on Wednesday. Key companies are in focus due to significant developments. SoftBank reduced i...
- Aurobindo Pharma enters biologics contract manufacturing with Rs 1,200-crore Telangana facilityAurobindo Pharma has launched TheraNym, a major biologics manufacturing plant in Telangana. This facility will produce biologic medicines f...
- Smallcaps & midcaps rally! Firstsource Solutions, Nuvama, Godfrey Phillips, other stocks jump up to 16%Smallcap and midcap stocks outperformed benchmarks on Friday, with select names rallying up to 16% despite broader market weakness. Gains w...
- Bombay HC backs GSK in Paxil trademark row against Shreya Life SciencesThe Indian subsidiary of the UK-based GSK PLC had urged the court to cancel the mark used by the local company in pharmaceutical and medici...
- Aurobindo unit terminates pact with Singapore firm to develop pentavalent vaccineAurobindo Pharma has terminated a license agreement through its subsidiary Auro Vaccines with Hilleman Laboratories for developing a pentav...
- Aurobindo joins hands with global pharma player to develop respiratory productsAurobindo Pharma's US subsidiary has partnered with a global pharmaceutical company to develop and sell respiratory products. The collabora...
- USFDA flags Telangana unit of Aurobindo Pharma armThe letter, issued on August 15, was later made public by the USFDA, which stated that there was failure to ensure the accuracy of data in ...
- Aurobindo Pharma signs pact with MSD to supply biologicals, to invest Rs.1000 crore on plantAurobindo Pharma's subsidiary, TheraNym Biologics Pvt Ltd, has signed a master service agreement with Merck Sharpe & Dohme Singapore for co...
- Director's arrest no way linked to operations: Aurobindo Pharma"Further to the disclosure of even date, the company further learnt that the arrest of P Sarath Chandra Reddy, whole-time director/promoter...
- Aurobindo Pharma arm's New Jersey unit gets warning letter from USFDAThis follows the earlier letter dated June 4, 2020, issuing an OAI (Official Action Indicated) status for this facility.
- Aurobindo, Sandoz call off USD 900 mn dealThe transaction if completed would have positioned the Hyderabad-based firm as the second largest dermatology player and the second largest...
- Aurobindo Pharma says co, subsidiary made party to litigation proceeding in USThe drug firm in a regulatory filing however said it is yet to receive a copy of the proceeding and denied what it said were 'baseless alle...
- Aurobindo Pharma arm enters pact to form JV in China with Luoxin"The percentage of shareholding in the joint venture company will be 30 per cent and 70 per cent between Helix and Luoxin," Aurobindo Pharm...
- Aurobindo Pharma inks pact to acquire Australian pharma firm's productBased out of Melbourne, Advent Pharmaceuticals is engaged in developing and commercialising generic inhaled medicines for global markets.
- Aurobindo Pharma to acquire under development product, related assets from Advent for $12.5mnThe acquisition is for a cash consideration of USD 12.5 million, it added. The indicative time period for completion of the acquisition is ...
- Aurobindo divests Australian arm to Eris PharmaAPL will continue to manufacture and supply products to Eris Pharma for Australian and New Zealand markets over the next few years.
- Aurobindo: Proceeds from stake sale to beef up cash flowsFrom being a low-margin pharma manufacturer, Aurobindo Pharma is transforming itself into a high-margin formulations player.
- Aurobindo’s Chinese gamble may pay offAfter three consecutive years of loss, Aurobindo Pharma is cutting loose its bleeding Chinese pharma subsidiary Aurobindo Tongling, while s...
- Aurobindo Pharma to divest Chinese armHyderabad-based Aurobindo Pharma has decided to disinvest its loss-making subsidiary in China while acquiring a small manufacturing unit in...
Load More
